Daniel D. Shoemaker, Chief Scientific Officer at FATE THERAPEUTICS INC (FATE), sold 48,600 shares at $36.11 ($1.8M) on 2020-09-14, disclosed to the SEC on 2020-09-16.
Open-market sale of $1.8M FATE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.40 | 1,400 | $50K | 2.8% |
| 2 | $36.11 | 17,887 | $646K | 36.6% |
| 3 | $36.11 | 17,887 | $646K | 36.6% |
| 4 | $37.12 | 5,713 | $212K | 12.0% |
| 5 | $37.12 | 5,713 | $212K | 12.0% |
| Total | $36.33 avg | 48,600 |
| $1.8M |
| 100% |
| Filing → |
| FATE | SELL | 2020-11-16 | $2.6M | — | Filing → |
| FATE | SELL | 2020-01-10 | $118K | — | Filing → |
| FATE | SELL | 2020-01-02 | $973K | — | Filing → |